ストックスクリーナーアプリを入手
1.83
0.27%
0.01
前日終値:
$1.84
開ける：
$1.85
24時間の取引高:
1.36M
Relative Volume:
0.76
時価総額：
$538.70M
収益：
$6.23M
当期純損益:
$-95.90M
株価収益率:
-4.6923
EPS:
-0.39
ネットキャッシュフロー:
$-68.47M
1週間 パフォーマンス:
-3.40%
1か月 パフォーマンス:
+29.93%
6か月 パフォーマンス:
+66.22%
1年 パフォーマンス:
+6.65%
1日の値動き範囲:
$1.82
$1.915
1週間の範囲:
$1.81
$2.005
52週間の値動き範囲:
$0.6513
$2.17
Precigen Inc Stock (PGEN) Company Profile
名前
Precigen Inc
セクター
電話
301-556-9900
住所
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD
PGEN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PGEN
Precigen Inc
|
1.825 | 560.84M | 6.23M | -95.90M | -68.47M | -0.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.04 | 123.00B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
549.76 | 59.66B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
324.94 | 41.84B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.37 | 33.98B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
290.44 | 27.67B | 3.81B | -644.79M | -669.77M | -6.24 |
Precigen Inc Stock (PGEN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-03-22 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2023-05-23 | 開始されました | JP Morgan | Neutral |
| 2022-11-18 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-02-25 | 開始されました | Stifel | Buy |
| 2021-02-22 | 開始されました | Wells Fargo | Overweight |
| 2021-02-18 | 開始されました | B. Riley Securities | Buy |
| 2020-05-08 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Precigen Inc (PGEN) 最新ニュース
HC Wainwright Predicts Precigen’s Q1 Earnings (NASDAQ:PGEN) - Defense World
Why Precigen Inc. stock attracts strong analyst attentionStable Growth Stock Picks - Newser
What makes Precigen Inc. stock price move sharplyBig Profit Small Risk Alerts - Newser
How Precigen Inc. stock performs during market volatilityMoney Making Low Risk Plans - Newser
Precigen (NASDAQ:PGEN) Upgraded at Wall Street Zen - Defense World
Precigen Inc (NASDAQ: PGEN) Up 15.99% This Year: What To Expect Next - Stocksregister
Precigen's PRGN-2012: A Rare Disease Breakthrough Awaits FDA Decision in August 2025 - AInvest
Precigen: August Is Pivotal For This Biotech Innovator - Seeking Alpha
Precigen Announces Key Approvals at Annual Meeting - TipRanks
Precigen chief commercial officer: How AI is impacting rare disease marketing - Medical Marketing and Media
Closing Strong: Precigen Inc (PGEN) Ends at 1.42, Down -7.79 from Last Close - DWinneX
High Growth Tech Stocks To Watch In The US June 2025 - simplywall.st
Bank of America Corp DE Has $232,000 Position in Precigen, Inc. (NASDAQ:PGEN) - Defense World
Precigen stock price target maintained at $6 by JMP on RRP therapy - Investing.com Nigeria
Precigen’s SWOT analysis: gene therapy firm’s stock poised for potential breakthrough - Investing.com Australia
Precigen (NASDAQ:PGEN) Given “Market Outperform” Rating at JMP Securities - Defense World
JMP Securities Reiterates PGEN with Market Outperform Rating | P - GuruFocus
JMP Securities Reiterates PGEN with Market Outperform Rating | PGEN Stock News - GuruFocus
Precigen, Inc.'s (NASDAQ:PGEN) market cap touched US$455m last week, benefiting both private equity firms who own 33% as well as institutions - Yahoo Finance
Cantor Fitzgerald Weighs in on Precigen FY2026 Earnings - Defense World
BNP Paribas Financial Markets Acquires New Position in Precigen, Inc. (NASDAQ:PGEN) - Defense World
ProShare Advisors LLC Buys 10,900 Shares of Precigen, Inc. (NASDAQ:PGEN) - Defense World
Top 5 Synthetic Biology Public Companies (June 2025) - Securities.io
Precigen, Inc. (NASDAQ:PGEN) Shares Acquired by Cetera Investment Advisers - Defense World
Precigen, Inc. (NASDAQ:PGEN) Shares Purchased by Northern Trust Corp - Defense World
D. E. Shaw & Co. Inc. Sells 792,731 Shares of Precigen, Inc. (NASDAQ:PGEN) - Defense World
Precigen (NASDAQ:PGEN) Downgraded to “Sell” Rating by Wall Street Zen - Defense World
Precigen, Inc. Reports Q1 2025 Financial Results - TipRanks
FY2025 EPS Estimates for Precigen Cut by Cantor Fitzgerald - Defense World
HC Wainwright Decreases Earnings Estimates for Precigen - Defense World
FY2027 EPS Estimates for Precigen Reduced by HC Wainwright - Defense World
Precigen, Inc. (NASDAQ:PGEN) Shares Sold by Price T Rowe Associates Inc. MD - Defense World
Cantor Fitzgerald Reiterates “Overweight” Rating for Precigen (NASDAQ:PGEN) - Defense World
Precigen First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Stifel Financial Corp Acquires 58,657 Shares of Precigen, Inc. (NASDAQ:PGEN) - Defense World
Cantor Fitzgerald maintains Overweight on Precigen stock By Investing.com - Investing.com South Africa
Precigen (PGEN) Rating Reaffirmed as Overweight by Cantor Fitzge - GuruFocus
Precigen (PGEN) Rating Reaffirmed as Overweight by Cantor Fitzgerald | PGEN Stock News - GuruFocus
JMP maintains Precigen stock $6 target on PRGN-2012 optimism By Investing.com - Investing.com Nigeria
JMP maintains Precigen stock $6 target on PRGN-2012 optimism - Investing.com Australia
Cantor Fitzgerald maintains Overweight on Precigen stock - Investing.com
Precigen Reports First Quarter 2025 Financial Results and Business Updates - StreetInsider
Precigen Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Precigen Inc (PGEN) Q1 2025 Earnings: Revenue Surges 26% to $1.4 - GuruFocus
Precigen Reports First Quarter 2025 Financial Results and Busine - GuruFocus
Precigen Reports First Quarter 2025 Financial Results and Business Updates | PGEN Stock News - GuruFocus
Breakthrough RRP Treatment PRGN-2012 Nears FDA Decision with 51% Complete Response Rate - Stock Titan
Precigen Inc (PGEN) 財務データ
収益
当期純利益
現金流量
EPS
3.69%
2.49%
大文字化:
|
ボリューム (24 時間):